µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© =6N=5JePB
h7S;
4]
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 6=x]20
1¡¢Co-stimulators (or co-stimulating molecules) pV1;gqXNS
2¡¢NK-kB iZ0(a
3¡¢Immunoglobulin superfamily rEWuWv$
4¡¢antigen-presenting cell (APC) 4-9cp=\PE
5¡¢death domain n.,ZgLx["
6¡¢CCR and CXCR }:*?w>=
7¡¢Lectin (or mitogen) COd~H
8¡¢Clusters of differentiation, CD)
$?9u;+jIR
9¡¢B7 family RK_z!%(P
10¡¢Cytotoxic T lymphocyte, CTL) e.(RhajB
11¡¢IL-15 and IL-15 receptor (IL-15R) ncpA\E;ff^
12¡¢MHC restriction QwuSo{G
13¡¢Affinity-chromatography 2]r5e;
14¡¢Cyctosprin A, CsA ,S?:lQuK5
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) ]ed7Q3lq
}}wSns
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© VotI5O $
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 @Q
:?,
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ YT@N$kOg_
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ Mi`t
$hmP
ke'OT>8
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© 4 ijZQ
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ zeH=py[
n
ѪҺ²¡Ñ§×¨Òµ£º t2q
WB[r
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿